US Tech 100

19,631.20

0.53%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

BNTX

BioNTech (BNTX)

BioNTech SE

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BNTX

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
03/04/2025	4:05PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
02/27/2025	7:57AM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BNTX	BioNTech SE
02/24/2025	6:45AM	GlobeNewswire Inc.	BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025	NASDAQ:BNTX	BioNTech SE
02/20/2025	7:53AM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BNTX	BioNTech SE
02/20/2025	7:50AM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BNTX	BioNTech SE
02/04/2025	11:15AM	IH Market News	Moderna, BioNTech Shares Down After Senate Committee Vote To RFK Jr.’s Nomination	NASDAQ:BNTX	BioNTech SE
02/03/2025	7:02AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
02/03/2025	6:45AM	GlobeNewswire Inc.	BioNTech Completes Acquisition of Biotheus	NASDAQ:BNTX	BioNTech SE
01/14/2025	6:58AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
01/14/2025	6:45AM	GlobeNewswire Inc.	BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:BNTX	BioNTech SE
12/27/2024	7:25AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
12/27/2024	7:21AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
12/13/2024	5:56PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BNTX	BioNTech SE
12/13/2024	4:01PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
12/11/2024	5:25PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BNTX	BioNTech SE
12/09/2024	6:35PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BNTX	BioNTech SE
12/06/2024	5:57PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BNTX	BioNTech SE
11/27/2024	5:50PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BNTX	BioNTech SE
11/26/2024	6:37PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BNTX	BioNTech SE
11/25/2024	5:06PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BNTX	BioNTech SE
11/15/2024	5:12PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BNTX	BioNTech SE
11/14/2024	7:38AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
11/13/2024	5:00PM	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:BNTX	BioNTech SE
11/13/2024	6:49AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
11/13/2024	6:45AM	GlobeNewswire Inc.	BioNTech to Acquire Biotheus to Boost Oncology Strategy	NASDAQ:BNTX	BioNTech SE
11/12/2024	7:39AM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BNTX	BioNTech SE
11/04/2024	6:57AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
11/04/2024	6:53AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNTX	BioNTech SE
11/04/2024	6:45AM	GlobeNewswire Inc.	BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update	NASDAQ:BNTX	BioNTech SE
10/31/2024	7:45AM	GlobeNewswire Inc.	BioNTech to Host Innovation Series R&D Day on November 14, 2024	NASDAQ:BNTX	BioNTech SE